共 50 条
- [41] PHASE-II STUDY OF ICRF-159 (NSC-129943) IN ADVANCED COLORECTAL CARCINOMA CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (04): : 761 - 763
- [42] ICRF-159 VERSUS POLYCHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER CANCER TREATMENT REPORTS, 1976, 60 (07): : 947 - 948
- [43] EVALUATION OF MELPHALAN, ICRF-159, AND HYDROXYUREA IN METASTATIC PROSTATE CANCER - PRELIMINARY-REPORT CANCER TREATMENT REPORTS, 1977, 61 (02): : 311 - 312
- [44] ICRF-159 VS POLYCHEMOTHERAPY IN NON-OAT CELL LUNG-CANCER PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 19 - 19
- [46] PHASE-II TRIAL OF RAZOXANE (ICRF-159) IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK PREVIOUSLY EXPOSED TO SYSTEMIC CHEMOTHERAPY CANCER TREATMENT REPORTS, 1982, 66 (03): : 557 - 558
- [50] ADJUVANT TREATMENTS FOR COLORECTAL-CANCER SEMAINE DES HOPITAUX, 1995, 71 (33-34): : 1000 - 1002